Legal & General Group PLC Prothena Corp Public LTD CO Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

A detailed history of Legal & General Group PLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Legal & General Group PLC holds 41,535 shares of PRTA stock, worth $832,361. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,535
Previous 38,875 6.84%
Holding current value
$832,361
Previous $962,000 10.91%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$19.54 - $26.15 $51,976 - $69,559
2,660 Added 6.84%
41,535 $857,000
Q1 2024

May 14, 2024
BUY
$24.75 - $40.66 $11,830 - $19,435
478 Added 1.24%
38,875 $962,000
Q4 2023

Feb 15, 2024
SELL
$32.31 - $52.32 $3,392 - $5,493
-105 Reduced 0.27%
38,397 $1.4 Million
Q3 2023

Nov 14, 2023
BUY
$47.3 - $70.6 $35,664 - $53,232
754 Added 2.0%
38,502 $1.86 Million
Q2 2023

Aug 14, 2023
BUY
$48.26 - $78.59 $67,033 - $109,161
1,389 Added 3.82%
37,748 $2.58 Million
Q1 2023

May 15, 2023
BUY
$46.97 - $58.27 $907,695 - $1.13 Million
19,325 Added 113.45%
36,359 $1.76 Million
Q4 2022

Feb 14, 2023
BUY
$52.05 - $65.0 $5,309 - $6,630
102 Added 0.6%
17,034 $1.03 Million
Q3 2022

Nov 14, 2022
BUY
$25.16 - $60.63 $21,713 - $52,323
863 Added 5.37%
16,932 $1.03 Million
Q2 2022

Aug 22, 2022
BUY
$22.73 - $39.98 $31,685 - $55,732
1,394 Added 9.5%
16,069 $437,000
Q1 2022

May 16, 2022
BUY
$30.27 - $49.22 $6,871 - $11,172
227 Added 1.57%
14,675 $537,000
Q4 2021

Feb 14, 2022
BUY
$42.11 - $73.26 $15,412 - $26,813
366 Added 2.6%
14,448 $713,000
Q3 2021

Nov 15, 2021
BUY
$48.2 - $78.89 $293,779 - $480,834
6,095 Added 76.31%
14,082 $1 Million
Q2 2021

Aug 12, 2021
BUY
$21.63 - $57.65 $18,580 - $49,521
859 Added 12.05%
7,987 $410,000
Q1 2021

May 17, 2021
BUY
$11.0 - $28.24 $5,269 - $13,526
479 Added 7.2%
7,128 $179,000
Q3 2020

Nov 13, 2020
SELL
$9.93 - $13.47 $13,772 - $18,682
-1,387 Reduced 17.26%
6,649 $66,000
Q2 2020

Aug 14, 2020
SELL
$9.56 - $12.51 $8,202 - $10,733
-858 Reduced 9.65%
8,036 $84,000
Q1 2020

May 14, 2020
SELL
$7.54 - $15.77 $12,561 - $26,272
-1,666 Reduced 15.78%
8,894 $95,000
Q3 2019

Nov 13, 2019
BUY
$6.89 - $10.45 $18,699 - $28,361
2,714 Added 34.59%
10,560 $83,000
Q1 2019

May 15, 2019
SELL
$10.32 - $14.49 $69,814 - $98,024
-6,765 Reduced 46.3%
7,846 $95,000
Q4 2018

Feb 15, 2019
BUY
$8.73 - $13.74 $8,939 - $14,069
1,024 Added 7.54%
14,611 $151,000
Q2 2018

Aug 10, 2018
SELL
$10.99 - $44.21 $6,396 - $25,730
-582 Reduced 4.11%
13,587 $198,000
Q1 2018

May 17, 2018
SELL
$27.95 - $45.04 $73,173 - $117,914
-2,618 Reduced 15.6%
14,169 $520,000
Q4 2017

Feb 13, 2018
BUY
$35.44 - $63.76 $594,931 - $1.07 Million
16,787
16,787 $630,000

Others Institutions Holding PRTA

# of Institutions
182
Shares Held
42.7M
Call Options Held
77.7K
Put Options Held
92.7K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $940M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email